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Abstract Background: Morbidity is deﬁned as a state of being unhealthy or of experiencing an aspect of health
that is “generally bad for you”, and postoperative morbidity linked to paediatric cardiac surgery encompasses a
range of conditions that may impact the patient and are potential targets for quality assurance.Methods: As part of
a wider study, a multi-disciplinary group of professionals aimed to deﬁne a list of morbidities linked to paediatric
cardiac surgery that was prioritised by a panel reﬂecting the views of both professionals from a range of disciplines
and settings as well as parents and patients. Results:We present a set of deﬁnitions of morbidity for use in routine
audit after paediatric cardiac surgery. These morbidities are ranked in priority order as acute neurological event,
unplanned re-operation, feeding problems, the need for renal support, major adverse cardiac events or never
events, extracorporeal life support, necrotising enterocolitis, surgical site of blood stream infection, and
prolonged pleural effusion or chylothorax. It is recognised that more than one such morbidity may arise in the
same patient and these are referred to as multiple morbidities, except in the case of extracorporeal life support,
which is a stand-alone constellation of morbidity. Conclusions: It is feasible to deﬁne a range of paediatric cardiac
surgical morbidities for use in routine audit that reﬂects the priorities of both professionals and parents.
The impact of these morbidities on the patient and family will be explored prospectively as part of a wider
ongoing, multi-centre study.
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Background
Morbidity is deﬁned as a state of being unhealthy or of
experiencing an aspect of health that is “generally bad
for you”. Morbidity associated with paediatric cardiac
surgery is illness or lack of health that has a temporal
connection to such an operation, and as such may
be regarded as an adverse outcome. The Society of
Thoracic Surgeons Taskforce Subcommittee on Patient
Safety has deﬁned a range of unwanted events that may
contribute to postoperative morbidity, including
complications, adverse events, harm, medical error or
injury, and near misses.1 This Patient Safety Taskforce
further noted that in the current era of falling mortality
rates after paediatric cardiac surgery, improvement
in healthcare as measured by reduction in adverse
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outcomes is more likely when unwanted events are
acknowledged, measured, and responded to in terms of
healthcare delivery1.
The main focus of our study, which has a national
setting in the United Kingdom, is upon early paedia-
tric cardiac surgical morbidities that are considered
potentially avoidable, reducible, or can be mitigated.
This is important to achieve as children who experience
prolonged hospitalisation with complications, which
are occurrences associated with an intervention that
represent a departure from the desired course of events
and are linked to suboptimal outcome1, are at greater
risk of death2,3 Furthermore, over the long term,
children with speciﬁc heart conditions who experienced
prolonged stays in hospital following surgery also
developed higher levels of neurological disability.4,5
Prolonged stays in hospital may be required when a
patient takes longer to recover after surgery because of
complications, but it is well recognised that prolonged
hospitalisation may itself expose patients to the
likelihood of further hospital-associated adverse events.
A signiﬁcant complication of paediatric cardiac surgery
and mechanical circulatory support is linked to
neurological disability in around 50% of cases6 and
may cost in excess £10,000/day to implement.7,8
Routine audit of postoperative mortality is well
established in the United Kingdom via the National
Congenital Heart Diseases Audit (NCHDA),9 which
has published centre-speciﬁc results of individual
operations online since 2005. Stakeholders including
children’s heart surgery programmes, congenital
heart patient support groups, and National
Congenital Heart Diseases Audit share a goal of
reporting morbidity, but acknowledge that to enable
routine monitoring of morbidities approaches to data
analysis and display must be developed alongside
deﬁning suitable measures for routine use. A series of
detailed articles by professionals from the United
States of America-based Multi-Societal Database
Committee for Pediatric and Congenital Heart
Disease proﬁled an extensive range of complications
incorporating all organ systems.10–17 The Society of
Thoracic Surgery database selected a narrower
range of deﬁned major complications that were
retrospectively available within the Registry, and
demonstrated that rates varied from 1 to 38%
with greater prevalence at increased procedural
complexity.18 A further study indicated that
prospective monitoring of complications may lead to
greater case ascertainment, and hence a perception
of higher complication rates19.
Views may differ between professionals and non-
professionals over what exactly the term morbidity
refers to, and which morbidity events are most impor-
tant. A recent study showed differing perceptions and
priorities between clinicians and patients regarding
chronic obstructive pulmonary disease services and
outcomes.20 Focus groups and formal consensus
methods have been used to elicit patient and carer
perspectives and determine group priorities in many
contexts.21 The nominal group technique was success-
fully used among general practitioners to identify
prioritised lists of quality markers for the management
of children in general practice21 and by kidney trans-
plant patients in ranking outcomes by importance.22
Our study, which aimed to identify the incidence
and impact of important early morbidities following
paediatric cardiac surgery,23 has been undertaken
within the context of the United Kingdom National
Health Service. As is depicted in Figure 1, which dis-
plays our study methodology, we utilised information
from a systematic review of the literature that screened
1169 publications, an online discussion forum between
families of patients with CHD, and three focus groups
with CHD families run by the patient and family
support group Children’s Heart Federation, to identify,
as far as possible, the entire range of known morbidity
events. A group representing individuals from a
range of backgrounds – the “Selection Panel” – which
comprised 15 people – three family representatives,
three paediatric cardiac surgeons, two paediatric
intensive care doctors, two paediatric cardiologists, two
paediatricians, a paediatric intensive care nurse, a
clinical nurse specialist, and a clinical psychologist with
experience of working with children with CHD and
their families – prioritised the possible morbidities
using the nominal group technique and secret voting.
Working in parallel alongside this “Selection Panel”,
a second group of professionals, referred to as the
“Deﬁnition Panel” (see Acknowledgements), worked
with the prioritised list of potential morbidities to
both deﬁne and assess the practicality of measuring
them in routine clinical practice. This article details the
deﬁnitions of morbidity that the panel recommended.
Methods
Development of operational deﬁnitions for routine
morbidity monitoring
Over 1 year, we convened two meetings of a surgical
morbidity “Deﬁnition Panel” that included three
paediatric cardiac surgeons, where one was the chair,
three paediatric cardiologists, with one specialising
in adult CHD, three paediatric intensive care
specialists, and two children’s heart disease nurses.
The “Deﬁnition Panel” had the following goals:
∙ Establish diagnostic criteria that constitute the
deﬁnition of each of the morbidities, as prioritised
by the “Selection Panel”.
∙ Deﬁne the measurement protocol for each of the
morbidities, including any aspects that require
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additional specialist input or alternatively surveil-
lance outside the tertiary centre.
∙ Outline the minimum standards of the clinical
pathway and necessary referrals and treatment for
children who experience morbidities over the ﬁrst
6 months after surgery.
This third part of the study drew upon information
from the literature review and any relevant, established
guidelines.10–17,24
In the ﬁrst phase of the study, conducted through an
initial face-to-face meeting followed by e-mail corres-
pondence, the group provided the “Selection Panel”
with views as to whether each candidate morbidity
nominated by the ﬁrst meeting of the “Selection Panel”
was deﬁnable, measureable, and feasible to measure in
routine practice, highlighting any additional issues
identiﬁed in relation to each morbidity; one or two
clinical leads were identiﬁed to take forward each of the
individual shortlisted morbidities, utilising both e-mail
and web-based interactions to develop each morbidity
deﬁnition, reporting back at the second meeting of the
deﬁnition group with an agreed package to sign off.
Clinical leads consulted with other experts in the
relevant ﬁeld in order to optimise deﬁnitions and
protocols where necessary. The protocols for identiﬁca-
tion, measurement, and management of shortlisted
morbidities, including the timings of measurements,
were designed for use in a multi-centre evaluation of
morbidity incidence and impact, with suitability for
routine use as a key requirement.
The morbidity deﬁnitions were implemented by a
small group of nurses, intensive care doctors, and
cardiothoracic surgeons within ﬁve children’s heart
centres based in the United Kingdom over a period of
2 months and used to prospectively record cases of
morbidity as part of a wider research study.23 During
this time period, the deﬁnitions underwent further
reﬁnement and clariﬁcation in order to ensure that
they were workable in the context of routine audit
within the National Health Service.
Results
Morbidity deﬁnitions
Each deﬁnition is described in turn incorporating
the timescale for identiﬁcation of the morbidity,
the deﬁnition, measurement protocol, and early
Figure 1.
The process that was followed for the selection of morbidities. A list of candidate morbidities was generated on the basis of a combination of
systematic review of the literature, three focus groups with parents of children with CHD and young people with CHD, and an online
discussion forum with CHD families. Morbidities were considered by a “Selection Panel” consisting of professionals from a range of
backgrounds and lay people and were selected using the Nominal Group Technique and Secret Voting. The deﬁnitions of selected morbidities
were undertaken by a group of United Kingdom-based specialist practitioners as listed in the report referred to as the “Deﬁnition Panel”.
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management protocol in brief as described by the
group. Morbidities are listed in priority order as
determined by the selection panel.
Multiple morbidities and items not included
Within the context of the present study,23 which aims
to prospectively measure the incidence and impact of
deﬁned morbidity events, the approach to the number
of morbidities in a given patient will be to identify
single morbidity events as deﬁned (1–9), extracorporeal
life support morbidity events, which may incorporate
further identiﬁed morbidities alongside, and multiple
morbidities in instances where a patient has one or
more morbidities excluding extracorporeal life support.
The “Selection Panel” further highlighted the
importance of prolonged hospitalisation and poor com-
munication between the treating team and the family,
which they considered to be morbidities. It was noted by
the deﬁnition panel that prolonged hospitalisation is
linked to all post-procedural complications, and hence
including length of stay as a morbidity would make
measurement of the incidence of individual morbidities
very challenging. Length of stay data including venti-
lation times, ICU length of stay, and hospital length of
stay will be reviewed as part of the data analysis at the
end of the study.
The “Deﬁnition Panel” considered that there was
potential to deﬁne poor communication between the
treating team and family in the future, but that it
would necessarily involve asking parents about their
experience in a way that would involve new data
collection. The quality of communication between
the treating team and the family has previously been
assessed within the context of a patient satisfaction
survey for all paediatric inpatients in England
commissioned by the Care Quality Commission and
undertaken by the organisation Picker Institute
Europe.25 The survey questions were formally
developed using focus groups and were formally
validated. The Picker Institute agreed to assist the
deﬁnitions panel in identifying a short list of six
questions to ask parents about communication and
issued the research team with licence to allow our
study to use these questions for patients recruited to a
6-month follow up sub-study to delineate this issue
further. From a long list of 25 candidate questions
from the Picker Questionnaire identiﬁed by the
deﬁnition panel, Picker ran the following analysis:
∙ Frequency analysis to ascertain the percentage of
missing data and the percentage of patients
answering each of the possible responses.
∙ Inter-item correlation analysis and principal
component analysis to identify questions that
provided different dimensions of communication
experience.
Picker then advised the Deﬁnition Panel on ﬁve to
seven questions that could be asked of parents within
6 weeks of the patient’s primary operation. The
ﬁnal questions chosen by the Deﬁnition Panel after
discussion with Picker are as follows:
Q1. Did new members of staff treating your child
introduce themselves?
Q2. Were you encouraged to be involved in decisions
about your child’s care and treatment?
Q3.Were you told different things by different
people, which left you feeling confused?
Q4.Were the different members of staff caring for and
treating your child aware of their medical history?
Q5. Before the operation or procedure, did a member of
staff explain to you what would be done during the
operation or procedure?
Q6. Did a member of staff tell you what to do or who
to talk to if you were worried about your child
when you got home?
We did not set a threshold for what deﬁnes “poor
communication”; instead, we will explore the range
of responses among control and case patients in our
6-month follow-up sub-study and possible associa-
tions with other clinical factors as part of a secondary
data analysis.
Discussion
We present a list of consensus-based deﬁnitions of
morbidities arising with paediatric cardiac surgery that
have been designed for prospective audit. The prioritised
and deﬁnedmorbidities reﬂect a range of viewpoints and
priorities, including those of both professionals and
patients or parents. The professionals involved in our
study represent tertiary, secondary, and primary care,
and furthermore we have involvement in our study from
at least one professional from every specialist paediatric
cardiac surgical centre in the United Kingdom.
We note that the list contains morbidities that were
previously prioritised as “complications” by specialist
professionals and included in a recent consensus-based
statement from the United States of America-based
Multi-Societal Database Committee for Pediatric and
Congenital Heart Disease,26 which are extracorporeal
life support, renal support, pacemaker placement,
diaphragm palsy, new permanent neurological deﬁcit,
and re-operation, but our list also contains further items
not previously identiﬁed and prioritised, which are
feeding problems, prolonged pleural effusion, and sepsis.
Challenges and limitations
In reaching these deﬁnitions certain challenges arose.
Consideration of pre-procedural factors. A major
difﬁculty when contemplating the monitoring of
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morbidity following paediatric cardiac surgery is
achieving a distinction between the morbidity that
was present in the patient before the operation and
the new morbidities that arose after surgery. It must
be acknowledged that preoperative events such as
existing congenital diagnoses and patient condition
are inextricably linked to the postoperative
journey,3,5 and indeed both preoperative and
postoperative events matter for the patient.
Preoperative events may also potentially be subject
to quality control – for example, the collapse of a
neonate from late diagnosis of heart disease leads to
higher rates of multiple organ failure27 and may be
averted by antenatal diagnosis and prospective
management of the circulation.28 Nonetheless, our
focus is upon early outcomes after paediatric cardiac
surgery and not on the entire care pathway; therefore,
the deﬁnitions are designed to delineate postoperative
events as clearly as possible. The delineation of new
neurological morbidity in a postoperative patient
may be challenging because of the inherent
difﬁculties of assessing (in particular) small infants
who may be critically ill. Prospective serial evaluation
including preoperative and postoperative scans and
detailed neurodevelopmental follow-up is ideal;
however, this is not feasible within a United
Kingdom National Health Service context, where
cranial scans may only be undertaken on the basis of
clinical indicators of suspected neurological injury,
and hence our deﬁnition is pragmatic by necessity,
although we hope that in the future it will be
supplemented by enhanced methods of assessment.
Post-procedural timing. Conventionally, the time
horizon linked to surgical complications has been
considered as 30 days following the operation,26 and
for mortality outcomes Registries such as Society of
Thoracic Surgery view the relevant time horizon as
within the same operative hospitalisation or 30 days,
whichever is longer.29 For the majority of morbidity
deﬁnitions, the time limit of either within 30 days or
within the same hospitalisation was applied (see
Table 1), based on what was considered most
appropriate for the individual morbidity event.
Certain morbidities, particularly those deﬁned by
the use of technology, such as renal support and
extracorporeal life support, are only likely to occur
within a hospitalisation, whereas others may occur at
any time point over an operated child’s lifespan – for
example, re-operation, endocarditis, and feeding
problems – and hence a time limit was placed
accordingly in order to enhance the feasibility of
postoperative audit, despite this time limit in some
cases appearing arbitrary. It was noted that deep
surgical site infection or mediastinitis, although
always linked to cardiac surgery, may arise after
discharge home and later than 30 days after surgery,
and thus the timeline was extended for this
morbidity.
Consistency and complexity of deﬁnitions. There are
inherent practical difﬁculties with prospective audit
of complex outcome measures; this is one reason for
the historic focus on mortality as an outcome as this is
much easier to measure than morbidity. For some
morbidities, a treatment indicating the presence of
morbidity was considered the better option rather
than basing the diagnosis on clinical ﬁndings. This
applies to the postoperative morbidities of renal
failure, diaphragm paralysis, and feeding problems,
for which postoperative renal support, the need for
diaphragm plication, and technology-assisted feeding
at discharge were selected as the most objective
deﬁnitions available. A concern with using a
treatment rather than a diagnosis as a measure of
morbidity is that treating centres may initiate
therapy at differing thresholds. During the course
of our study, additional data items will be collected
to explore the potential for such variation. As an
example, practice patterns with respect to
technology-assisted feeding in cardiac babies vary
widely between geographic regions and diagnostic
groups, and it is acknowledged that the audit of
feeding problems at discharge rather than over time
in outpatients may not capture the full picture.30 For
the case of extracorporeal life support, there is an
inextricable link between the severe condition of
patients requiring this therapy and the burden of the
treatment itself,5,26,31 and therefore this is reasonably
widely accepted as a major morbidity after paediatric
cardiac surgery by all stakeholder groups.1 Moreover,
considering the example of renal failure, given the
complex inter-relationship between the patient’s
preoperative condition, which may incorporate renal
dysfunction32, their age, especially very young
neonates as is common27, their body mass index,
which may be low in CHD, their postoperative
condition, and measures of renal function, a
deﬁnition involving a speciﬁed measure of renal
function was considered to be impractical to deﬁne
for routine use. Of note, it proved infeasible for the
panel to agree a clear and usable deﬁnition of low
cardiac output syndrome for use in routine audit.
Future steps
The deﬁnitions presented in Table 1 incorporate
feedback from ﬁve United Kingdom paediatric
cardiac surgical centres that have been using them
prospectively for 5 months with paediatric cardiac
surgery patients; however, we acknowledge that as
yet the long-term practicalities involved in monitor-
ing these morbidities are unclear. The next stage is to
report on the morbidities for the purposes of quality
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Table 1. Morbidities with timescale for identiﬁcation, deﬁnition, measurement protocol and minimum treatment protocol.
Morbidity Timescale for identiﬁcation Deﬁnition
Measurement protocol
(if additional to deﬁnition) Minimum treatment protocol
Acute
neurological
event
Includes neurological morbidities that,
based on best clinical judgement, arose as
new ﬁndings around the time of surgery
that were detected within the same
hospitalisation as the surgery. It is
recognised that in certain circumstances
such as where a child is very sick on life
support, pre-procedure assessment is
challenging, in these circumstances as full
an evaluation as possible to be completed,
incorporating serial assessments over time
Neurological events including: seizure, abnormal
movement (includes choreiform or athetoid), focal
neurological deﬁcit (includes hemiplegia and
monoplegia), intracranial haemorrhage, stroke,
brain death, reversible ischaemic neurological
dysfunction, hypoxic ischaemic encephalopathy,
spinal cord ischaemia, basal ganglia damage, or
brain stem injury (includes abnormal cough or
gag reﬂex)38
Includes new abnormality in any of the
following:
∙Electroencephalogram.
∙Brain scan (either CT or MRI)
∙Clinical evaluation
(seizures or movement disorder, focal
neurological signs, generalised
neurological signs, altered conscious level
including even brain death)
The treatment protocol is variable
depending on the type of neuro-
morbidity.
Specialist consultation with a
neurologist, a full evaluation of any brain
injury and neuro-developmental follow-
up would be a minimum
Unplanned
re-operation or
re-intervention
Unplanned re-interventions are procedures
outside the expected patient pathway,
which may be undertaken at any time
from the start of the postoperative
admission up until 30 days following the
primary operation. Additional procedures
or revisions undertaken within the
primary trip to the operating theatre
(incorporating return onto
cardiopulmonary bypass) are not included
in the deﬁnition of re-operation
Unplanned re-interventions include procedures
that were not intended during the planning
phase, follow an initial primary cardiac surgery
and result in “substantive alteration to heart”
incorporating cardiac bypass, cardiac non-bypass,
pacemaker placement, interventional
catheterisations, and also diaphragm plications
(which are not related to the heart itself). The
deﬁnition does not include support or other non-
cardiac surgery procedures
Unplanned return to the operating room
or cardiac catheter laboratory within
30 days
(excludes interventional catheters that
were planned preoperatively; excluding
delayed chest closure, excluding
procedures for bleeding)
(Includes diaphragm plication and
insertion of pacemaker for surgically
acquired arrhythmia)
Not applicable. The minimal assessment
is cardiovascular evaluation of the repair
with echocardiography and tolerance of
weaning from life supports
Feeding
problems
A diagnosis of postoperative feeding
problems should be considered during
recovery after surgery and before discharge
from the specialist centre either to home or
to secondary care if the child is unable to
feed normally. The goal is detection of
feeding problems which are new post-
surgery, and it is recognised that this may
be challenging where a child was not fed
preoperatively for cardiac reasons as
feeding ability will not have been assessed
objectively
A child may fail to feed normally following
paediatric cardiac surgery for a range of reasons
including gastro-oesophageal reﬂux, vocal cord
paralysis, oral-motor dysfunction, oral aversion,
and neurologic impairment.31 If for any of these
reasons a child is not able to orally feed or
completely orally feed and is tube dependent at
discharge from the tertiary centre or at 30 days (if
he or she is otherwise clinically stable enough to
feed at that time point), then a postoperative
feeding problem will be diagnosed
The requirement for any feeding support.
Includes via the intravenous route or via
an enteral tube.
Excludes feeding support that was
present to treat a primary problem
diagnosed before the surgery, feeding
support related to an episode of
necrotising enterocolitis, and feeding
support because the child dislikes a
special diet
Treatment includes assessment by the
dietician, speech and language therapist
and of the patient’s weight. Progress with
feeding should be monitored by the
clinical care team responsible at each
stage of the journey
Need for renal
replacement
therapy
Includes renal replacement therapy when
initiated as a new support at any time from
the start of the postoperative admission to
ICU up until 30 days following the
primary operation
The child requires renal replacement therapy
(peritoneal dialysis or haemoﬁltration) for renal
failure (oligo-anuria of >0.5ml/kg/hour and
elevated creatinine level for age) and or ﬂuid
overload. In patients where renal support is
required alongside extracorporeal life support, the
primary morbidity is viewed as extracorporeal life
support
The measurement protocol is simply the
presence of (new) renal support.
(Excludes renal support on extracorporeal
life support). Data on renal biochemistry
and urine output will be collected
Instigation of effective renal replacement
therapy.
If recovery of kidney function does not
occur within 3–5 weeks then
consultation with paediatric renal
physician is required
752
C
ardiology
in
the
Y
oung
M
ay
2017
https:/w
w
w
.cam
bridge.org/core/term
s. https://doi.org/10.1017/S1047951116001256
D
ow
nloaded from
 https:/w
w
w
.cam
bridge.org/core. U
niversity C
ollege London, on 05 M
ay 2017 at 14:02:23, subject to the C
am
bridge C
ore term
s of use, available at
Major adverse
cardiac events or
never events
Events within this morbidity may be
identiﬁed during the tertiary hospital stay
(either ward or ICU) following the primary
surgery
This morbidity includes
cardiac arrest, where the child receives any chest
compressions or deﬁbrillation
Chest re-opening on the ICU or ward for any
reason
Major haemorrhage in the ICU following surgery
A “Never Event” applicable to paediatric cardiac
surgery as selected from the “Never Events” list
published for National Health Service for 201539
(Including wrong site or wrong patient surgery,
wrong prosthesis surgery, retained foreign object
post-procedure, wrong route administration of
medication, transfusion or transplantation of
main red cell group incompatible blood
components or organs, misplaced naso-gastric or
oro-gastric tubes
Tissue injury to limb or vital organ such as
perforated viscus or ischaemic limb injury
Major haemorrhage is deﬁned as bleeding
>10ml/kg/hour on ICU for 2
consecutive hours.
A “Never Event” includes the events
listed plus harm to the patient, for
example: if a naso-gastric tube is
misplaced, detected and removed in a
timely manner before any harm is done
then this is not a “Never Event”.
Conversely, if the misplaced naso-gastric
tube is not noted, and feed is given into
the bronchus, then this is a “Never
Event”
All events will results in immediate
treatment as part of current practice
Extracorporeal
life support
Extracorporeal life support following
surgery and before discharge from the
tertiary hospital, including the rare cases
when a child was on extracorporeal life
support before surgery
This morbidity is deﬁned by the presence of an
extracorporeal life support system connected to
the patient following the operation, whether it
was placed in the operating theatre or in the ICU,
and whether the indication was cardiac arrest, low
cardiac output state, poor cardiac function,
arrhythmia, residual or recurrent cardiac lesion,
pulmonary including pulmonary hypertension or
sepsis
It is recognised that children on
extracorporeal life support following
paediatric cardiac surgery have high rates
of other complications including renal
support, bleeding, sepsis, sternal re-
opening, and cardiac arrest.40 Where
such complications arise as part of
extracorporeal life support, the morbidity
is deﬁned as extracorporeal life support
The morbidity is in fact a treatment
modality offered so this is not applicable.
Centres offering extracorporeal life
support follow protocols based on those
provided by the extracorporeal life
support organisation24
Necrotising
enterocolitis
Necrotising enterocolitis as a new
diagnosis from after surgery until
discharge from the tertiary hospital
Necrotising enterocolitis class 1a or 1b,41 which
incorporates babies with systemic signs of
inﬂammation and abdominal clinical signs such
as distension or larger than normal gastric
aspirates or mild rectal bleeding but no
radiological changes are included, if a general
surgery specialist has seen the child and
commenced a course of intravenous antibiotics
and parenteral nutrition for ﬁve to seven days.
Cases of severe necrotising enterocolitis with
radiological signs systemic instability and bowel
perforation are also included
Data in respect of systemic clinical signs,
intestinal signs, and radiology will be
collected, as well as the treatments
deployed, thus enabling the necrotising
enterocolitis diagnosis to be graded
between 1a and 3b41
Consultation with general surgery and
further management in respect of
antibiotics, nutrition, radiological
investigation, and surgical intervention
Surgical site
infection and
blood stream
infection
Surgical site and blood stream infections
diagnosed within the hospital admission
following surgery or following
readmission to the same unit during
postoperative recovery, where the treating
clinical team assesses the infection to be
linked to the recent operation. It is noted
that mediastinitis may be detected more
Deep surgical site infection and/or mediastinitis
includes any infection of an incised wound that
undergoes any re-intervention by a surgeon (such
as opening of the wound, vacuum dressing),
mediastinitis and false aneurysm, independent of
culture positivity.
Blood stream infection includes both catheter
related and non-catheter related. Cases have
Deep surgical site infection excludes
superﬁcial site infection managed
without a surgeon’s reoperation by
conventional nurse dressing only, even if
the wound heals by secondary intention
The minimum treatment protocol
consists of antibiotics based on organism
and sensitivities, and where relevant the
removal of the line. Surgical intervention
may be required for deep surgical site and
in some cases of endocarditis. Both
conditions require prolonged antibiotic
therapy
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Table 1. Continued
Morbidity Timescale for identiﬁcation Deﬁnition
Measurement protocol
(if additional to deﬁnition) Minimum treatment protocol
than 30 days after cardiac surgery,42 hence
this time cut-off is not applicable
systemic signs of infection, a positive culture not
judged to be a contaminant, and in the case of line
related a catheter in place with positive cultures
from the line or from the line tip when removed
Endocarditis based on clinical, imaging or culture
evidence judged to be diagnostic of endothelial/
endocardial infection and its sequelae cardiac or
extra-cardiac
Prolonged
pleural effusion
or chylothorax
Prolonged pleural effusion is a post-
procedural effusion with duration greater
than 10 days. Chylothorax is diagnosed
from after surgery until discharge from the
tertiary hospital
Either a chylous pleural effusion or signiﬁcant
chylous pericardial effusion or signiﬁcant chylous
ascites or a prolonged non-chylous effusion that
necessitates thoracic drainage at least 10 days
following index cardiac surgery
Chylous effusions are characterised by
milky appearance and a pleural ﬂuid
white blood cell count of >1000 cells/μl
with lymphocytes >80%.32 If the child is
on normal feeds the triglyceride level in
the pleural ﬂuid will be >1.1mmol/L or
the ratio between the pleural triglyceride
level and the serum triglyceride level will
exceed 1
Diet consisting of medium-chain
triglycerides or low fat for chylothorax.
On a patient-by-patient basis other
treatments include parenteral nutrition,
octreotide infusion, intervention for
venous obstruction thoracic duct
ligation, and pleuradhesis
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assurance and to assess their impact on patients and
families with formal prospective analysis. We note
that analytical and graphical methods for the timely
reporting of risk-adjusted mortality outcomes for the
purposes of quality improvement are well established
in adult cardiac surgery practice33 and have been
developed by members of our research group for
paediatric cardiac surgery;34 two single-centre
studies have attempted to generate an aggregate
“Morbidity Index” by assigning subjective weights to
postoperative complications,35,36 and the Society for
Thoracic Surgeon group have attempted a similar
“Morbidity Score”.18 Condensing diverse morbidities
into a single score loses information, and recent work
on using graphical methods to routinely monitor a
range of morbidities highlighted the complexity
of graphically summarising multiple morbidities19
(see also commentary by Utley et al37). We intend to
report on the incidence and impact of the deﬁned
morbidities over the next few months: the ﬁndings of
these studies will inform future data collection for
national audit in the United Kingdom.
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